Phathom Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.21-$19.71 |
Market Cap | $742.7M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $114M |
Revenue Growth (YoY) | 439.4% |
Gross Profit (12 Mos) | $99.1M |
Diluted EPS | -$4.67 |
News
See moreYahoo Finance • 8 days ago
Phathom projects $165M–$175M 2025 revenue as GI sales focus accelerates VOQUEZNA growth
Yahoo Finance • 9 days ago
Phathom Pharmaceuticals (NASDAQ:PHAT) Surpasses Q2 Estimates with Strong VOQUEZNA Growth, Shares Jump 6% in Premarket
Yahoo Finance • 19 days ago
Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025
Yahoo Finance • 2 months ago
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Steven L. Basta M.B.A. |
Address | 100 Campus Drive, Florham Park, NJ, United States, 07932 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 427 |
